Watanabe, Ryo
Suzuki, Jun-ichi
Wakayama, Kouji
Maejima, Yasuhiro
Shimamura, Munehisa
Koriyama, Hiroshi
Nakagami, Hironori
Kumagai, Hidetoshi
Ikeda, Yuichi
Akazawa, Hiroshi
Morishita, Ryuichi
Komuro, Issei
Isobe, Mitsuaki
Article History
Received: 16 May 2016
Accepted: 1 February 2017
First Online: 7 March 2017
Competing interests
: Department of Clinical Gene Therapy is financially supported by AnGes MG, Novartis, Shionogi, Boeringher, and Rohto. Division of Vascular Medicine and Epigenetics is financially supported by AnGes MG, Daicel and Mitsubishi-Tanabe. R.M. is a founder and stockholder of AnGes MG and a former board member. Department of Advanced Clinical Science and Therapeutics is financially supported by AnGes MG.